8.Weight Gain in Women at Midlife: A Concise Review of the Pathophysiology and Strategies for Management.Mayo Clinic Proceedings
The digestive side effects can be significant enough that some patients decide to stop the medication
Cost, Insurance Driving Move to Compounded Drugs Compounded GLP-1 medications are not approved by the FDA, and the agency issued a warning in June calling them potentially risky for patients. This hasnt stopped patients from switching to the unapproved drugs, and 35% of patients who took compounded GLP-1s left from a name brand drug, according to Gallup
recovery timing helps replenish what illness depleted
retatrutide injectable is expected under a distinct brand name
Finally, several studies on post-bariatric surgery patients (Roux-en-Y gastric bypass) have observed a decreased preference for highly concentrated sweet foods, without significant changes in response to salty, sour, or bitter stimuli